Search research articles
Contact Us
Filters
Showing results (101-110 of 167) with videos related to
Page
of 17
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 6, 1998
Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients
Y Belkacémi, F Pène, E Touboul, et al.
Bone Marrow Transplantation
|
January 1, 1991
Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients
L Sutton, V Leblond, C Le Maignan, et al.
Experimental Hematology
|
December 1, 1987
T-cell depletion of bone marrow transplants: assessment of standard immunological methods of quantification
B Autran, F Beaujean, C Pillier, et al.
Bone Marrow Transplantation
|
June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle
A Pigneux, A Devergie, M Pochitaloff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1996
Cataractogenesis after total body irradiation
Y Belkacémi, M Ozsahin, F Pène, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center
V Leblond, L Sutton, R Dorent, et al.
Nouvelle Revue Francaise D'Hematologie
|
July 1, 1994
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91]
E Archimbaud, V Leblond, P Fenaux, et al.
Leukemia
|
August 23, 2001
Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis
V Lévy, R Porcher, V Leblond, et al.
The Journal of Clinical Investigation
|
May 29, 1998
Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia
P Yotnda, H Firat, F Garcia-Pons, et al.
Transplantation
|
August 15, 1994
Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation
D Rea, C Fourcade, V Leblond, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 167) with videos related to
Sort By:
Page
of 17
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 6, 1998
Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients
Y Belkacémi, F Pène, E Touboul, et al.
Bone Marrow Transplantation
|
January 1, 1991
Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients
L Sutton, V Leblond, C Le Maignan, et al.
Experimental Hematology
|
December 1, 1987
T-cell depletion of bone marrow transplants: assessment of standard immunological methods of quantification
B Autran, F Beaujean, C Pillier, et al.
Bone Marrow Transplantation
|
June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle
A Pigneux, A Devergie, M Pochitaloff, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1996
Cataractogenesis after total body irradiation
Y Belkacémi, M Ozsahin, F Pène, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center
V Leblond, L Sutton, R Dorent, et al.
Nouvelle Revue Francaise D'Hematologie
|
July 1, 1994
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91]
E Archimbaud, V Leblond, P Fenaux, et al.
Leukemia
|
August 23, 2001
Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis
V Lévy, R Porcher, V Leblond, et al.
The Journal of Clinical Investigation
|
May 29, 1998
Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia
P Yotnda, H Firat, F Garcia-Pons, et al.
Transplantation
|
August 15, 1994
Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation
D Rea, C Fourcade, V Leblond, et al.
Page
of 17